J0717
HCPCSCertolizumab pegol inj 1mg
Official HCPCS Level II long descriptor
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
HCPCS Level II code J0717 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Certolizumab pegol inj 1mg
Added to HCPCS: 2014-01-01
Nearby codes in J0
- J0701Inj. cefepime hcl (baxter)
- J0702Betamethasone acet&sod phosp
- J0703Inj, cefepime hcl (b braun)
- J0706Caffeine citrate injection
- J0712Ceftaroline fosamil inj
- J0713Inj ceftazidime per 500 mg
- J0714Ceftazidime and avibactam
- J0716Centruroides immune f(ab)
- J0720Chloramphenicol sodium injec
- J0725Chorionic gonadotropin/1000u
- J0735Clonidine hydrochloride
- J0736Inj, clindamycin phosp 300mg
- J0737Inj, clindamycin (baxter)
- J0738Hiv prep, inj, lenacapavir
- J0739Hiv prep, inj, cabotegravir
- J0740Cidofovir injection
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.